Interactions between genes involved in the antioxidant defence system and breast cancer risk

British Journal of Cancer

Volumn 95, Issue 4, 2006, Pages 525-531

  Oestergaard, M Z ^a   Tyrer, J ^a   Cebrian, A ^a   Shah, M ^a   Dunning, A M ^a   Ponder, B A J ^a   Easton, D F ^a   Pharoah, P D P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antioxidant defence; Breast cancer; Epistasis; Gene gene interactions

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; RIBONUCLEOTIDE REDUCTASE; THIOREDOXIN PEROXIDASE; THIOREDOXIN REDUCTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; CANCER RISK; CAT GENE; CLUSTER ANALYSIS; CONTROLLED STUDY; EPISTASIS; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; GPX1 GENE; GPX4 GENE; GSR GENE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIFACTOR DIMENSIONALITY REDUCTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOD1 GENE; SOD2 GENE; STATISTICAL ANALYSIS; TXN GENE; TXN2 GENE; TXNRD1 GENE; TXNRD2 GENE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 33747204839     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603272     Document Type: Article

References (25)

1. Carlborg O, Haley CS (2004) Epistasis: too often neglected in complex trait studies? Nat Rev Genet 5(8): 618-625
2. Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BAJ (2006) Tagging Single-Nucleotide Polymorphisms in Antioxidant Defense Enzymes and Susceptibility to Breast Cancer. Cancer Res 66(2): 1225-1233
3. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291): 1389-1399
4. Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 95(6): 448-457
5. Easton DF (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res 1(1): 14-17
6. Goode EL, Pharaoh PDP, Wareham N, Easton DF (2005) No evidence for population substructure within the EPIC-Norfolk cohort. 96th annual meeting of the American Association of Cancer Research. Annaheim, California
7. Hastie T, Tibshirani R, Friedman J (2001) The Elements of Statistical Learning: Data Mining, Inference and Prediction. Springer 472-480
8. Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 31(4): 273-300
9. Irizarry KJ, Merriman B, Bahamonde ME, Wong ML, Licinio J (2005) The evolution of signaling complexity suggests a mechanism for reducing the genomic search space in human association studies. Mol Psychiatry 10(1): 14-26
10. Levenstein MA, Yang Y, Ott J (2003) Statistical significance for hierarchical clustering in genetic association and microarray expression studies. BMC Bioinformat. 4(62): 1-9
11. Li S, Yan T, Yang JQ, Oberley TD, Oberley LW (2000) The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60(14): 3927-3939
12. Lichtenstein P, Holm NV, Verkasalo PK, Iliado A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2): 78-85
13. Marchini J, Donnelly P, Cardon LR (2005) Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 37(4): 413-417
14. Mates JM, Sanchez-Jimenez FM (2000) Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol 32(2): 157-170
15. McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261): 624-628
16. Mustacich D, Powis G (2000) Thioredoxin reductase. Biochem J 346: 1-8
17. Oberley TD, Oberley LW (1997) Antioxidant enzyme levels in cancer. Histol Histopathol 12(2): 525-535
18. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71(5): 800-809
19. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4(11): 850-860
20. Powis G, Montfort WR (2001) Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 30: 421-455
21. Powis G, Mustacich D, Coon A (2000) The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29(3-4): 312-322
22. Ray G, Husain SA (2002) Oxidants, antioxidants and carcinogenesis. Indian J Exp Biol 40(11): 1213-1232
23. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69(1): 138-147
24. Segre D, Deluna A, Church GM, Kishony R (2005) Modular epistasis in yeast metabolism. Nat Genet 37(1): 77-83
25. Townsend DM, Tew KD, Tapiero H (2003) The importance of glutathione in human disease. Biomed Pharmacother 57(3-4): 145-155